IRIS
ORIO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.610
AS - Asia 831
EU - Europa 776
AF - Africa 41
OC - Oceania 1
Totale 3.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.570
CN - Cina 344
SG - Singapore 312
IT - Italia 193
NL - Olanda 128
HK - Hong Kong 113
IE - Irlanda 103
DE - Germania 100
FI - Finlandia 99
SE - Svezia 61
VN - Vietnam 40
CA - Canada 36
CI - Costa d'Avorio 36
RU - Federazione Russa 26
GB - Regno Unito 21
UA - Ucraina 21
IN - India 12
CZ - Repubblica Ceca 7
FR - Francia 6
BE - Belgio 5
MX - Messico 4
EG - Egitto 3
ES - Italia 3
IQ - Iraq 3
PH - Filippine 3
NG - Nigeria 2
SA - Arabia Saudita 2
AU - Australia 1
IL - Israele 1
LT - Lituania 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.259
Salva come PNG Salva come JPEG
Città #
Chandler 297
Singapore 257
Millbury 133
Amsterdam 125
Hong Kong 113
Princeton 101
Santa Clara 95
Nanjing 88
Naples 88
Beijing 80
Jacksonville 75
Wilmington 49
Ashburn 41
Dong Ket 40
Nanchang 36
Boston 34
Seattle 29
Des Moines 26
Napoli 26
Ottawa 26
Munich 20
Shenyang 17
Helsinki 16
Jiaxing 14
Hebei 13
Norwalk 12
Dublin 11
Woodbridge 11
Changsha 10
Tianjin 10
Dearborn 9
Falls Church 9
Boardman 8
Redwood City 8
Brno 7
Kunming 7
Toronto 7
Moscow 6
Buffalo 5
Lawrence 5
Pune 5
Rome 5
Shanghai 5
Yellow Springs 5
Indiana 4
Los Angeles 4
Washington 4
Dallas 3
Falkenstein 3
Frankfurt am Main 3
Guangzhou 3
Imola 3
Kronberg 3
Lanzhou 3
Madrid 3
New York 3
Redmond 3
Zhenjiang 3
Ahmedabad 2
Ansbach 2
Brussels 2
Changchun 2
Council Bluffs 2
Courcelles 2
Frattamaggiore 2
Hangzhou 2
Milan 2
Ningbo 2
Pesaro 2
Saint-Fons 2
Salerno 2
Springfield 2
Tappahannock 2
Ann Arbor 1
Bangalore 1
Bratislava 1
Cambridge 1
Castel San Giorgio 1
Cernusco sul Naviglio 1
Delhi 1
Dongguan 1
Duncan 1
Giugliano In Campania 1
Handan 1
Harbin 1
Hefei 1
Huaibei 1
Kolkata 1
Kumar 1
Langfang 1
Laojunmiao 1
London 1
Long Beach 1
Manduria 1
Port Harcourt 1
Potenza 1
Quanzhou 1
Regensburg 1
Riyadh 1
Rothesay 1
Totale 2.086
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 71
Cardiopulmonary impairment in young women with polycystic ovary syndrome 59
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 56
Effects of neridronate treatment in elderly women with osteoporosis 55
Influence of nutrition on somatotropic axis: Milk consumption in adult individuals with moderate-severe obesity 52
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 51
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 51
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison 49
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 48
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 47
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 46
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 46
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 46
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 45
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 45
Metabolic and cardiovascular consequences of polycystic ovary syndrome 44
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 44
Low vitamin D status and obesity: Role of nutritionist 44
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 43
Endocrine Aspects of Environmental "Obesogen" Pollutants 43
Cardiovascular complications of obesity in adolescents 42
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 42
BISPHENOL A IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH LIVER-SPLEEN AXIS. 42
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 41
Androgens in polycystic ovary syndrome: the role of exercise and diet 40
Cardiovascular risk in women with polycystic ovary syndrome 40
Lifestyle changes in the management of adulthood and childhood obesity. 40
Vitamin D and thyroid disease: To D or not to D? 40
Water intake keeps type 2 diabetes away? Focus on copeptin 40
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 39
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 38
Evidence for altered adipocyte function in polycystic ovary syndrome 38
Cardiovascular risk in women with polycystic ovary sydrome 38
Adrenocortical tumors and insulin resistance: What is the first step? 38
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 37
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 37
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 37
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 37
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 37
Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome. 37
The integrity of the Growth Hormone and Insuline-like Growth Factor -1 axis as outcome predictor after Laparoscopic Adjustable Silicone Gastric Banding. 37
Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420-1426 37
Nutrition, inflammation and liver-spleen axis 37
THE GOOD AND BAD EFFECTS OF STATINS ON INSULIN SENSITIVITY AND SECRETION. 36
Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? 36
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 35
Tianeptine, an antiserotoninergic drug, increases GHRH release into the hypophyseal portal blood of the sheep 35
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 34
Cardiovascular complications of obesity 34
Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease 34
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 33
DAI NUOVI CRITERI DIAGNOSTICI ALLE RECENTI ACQUISIZIONI TERAPEUTICHE DELLA SINDROME DELL’OVAIO POLICISTICO. 33
Vitamin D and chronic diseases: the current state of the art 33
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 32
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 32
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 31
Effect of growth hormone on cardiac function 31
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 31
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 31
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 30
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 30
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome 29
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors. 28
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 27
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome 27
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 26
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 26
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept 26
Polycystic ovary syndrome and obesity: non pharmacological approaches 25
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 25
Failure of long-term therapy with sodium valproate in Cushing's disease. 24
Endocrine disorders during the first year after autologous stem-cell transplant 24
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 23
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 23
Serum 25-Hydroxyvitamin D Levels, Phosphoprotein Enriched in Diabetes Gene Product (PED/PEA-15) and Leptin-to-Adiponectin Ratio in Women with PCOS. 23
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 23
Gut: A key player in the pathogenesis of type 2 diabetes? 23
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 22
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 22
STUDY OF HOMOCYSTEINE LEVELS AND C677T POLYMORPHISM OF MTHFR IN YOUNG WOMEN WITH PCOS. 22
Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome: From bench to bedside 22
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 21
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 21
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 21
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. 20
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 20
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 19
Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome 19
Malattie Ipotalamo Ipofisarie- Tumori ipofisari secernenti 19
LA SINDROME METABOLICA NELLA SINDROME DELL’OVAIO POLICISTICO: IL RUOLO DELL’ESERCIZIO FISICO. 19
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 19
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 18
Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study 18
Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling 17
L’esercizio fisico nei soggetti obesi. 17
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 16
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS) 16
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 15
Relationships between inflammatory markers, visceral fat and maximal oxygen consumption in women with polycystic ovary syndrome. 15
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. 14
Totale 3.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 0 0 12 0 2 50 48 64
2020/2021154 3 6 15 11 6 41 13 0 9 3 6 41
2021/2022614 5 3 0 6 4 58 2 11 98 28 126 273
2022/2023728 115 64 22 59 81 60 10 55 92 127 35 8
2023/2024486 24 76 118 15 16 38 3 64 3 4 77 48
2024/2025663 135 132 29 28 50 157 132 0 0 0 0 0
Totale 3.355